Cita APA

Garcia-Guiñón, A., Abella Monreal, E., Ben Azaiz, R., & Fernández de Larrea Rodríguez, C. J. (2025). Real-world evidence of Carfilzomib, Lenalidomide and Dexamethasone (KRD) Scheme in patients with relapsed / refractory multiple myeloma.

Citación estilo Chicago

Garcia-Guiñón, Antoni, Eugenia Abella Monreal, Ran Ben Azaiz, y Carlos José Fernández de Larrea Rodríguez. Real-world Evidence of Carfilzomib, Lenalidomide and Dexamethasone (KRD) Scheme in Patients With Relapsed / Refractory Multiple Myeloma. 2025.

Cita MLA

Garcia-Guiñón, Antoni, Eugenia Abella Monreal, Ran Ben Azaiz, y Carlos José Fernández de Larrea Rodríguez. Real-world Evidence of Carfilzomib, Lenalidomide and Dexamethasone (KRD) Scheme in Patients With Relapsed / Refractory Multiple Myeloma. 2025.